期刊文献+

Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation 被引量:5

原文传递
导出
摘要 Background:Liver transplantation(LT)is one of the most effective surgical treatment for patients with end-stage liver disease.Steatosis is a contributor for inferior graft quality.But its impact and safety on transplantation was less assessed in Chinese patients.Methods:Graft steatosis and related information involved in recipients,donors and surgical procedures were retrospectively collected from 239 patients.Results:Donor macrosteatosis(MaS)caused about 2.14 and 2.80 folds of increment on patient and graft mortality.Dose-response analysis revealed prominent risk of grafts on overall patient/organ mortality when MaS content exceeded 10%(P<0.05).Noteworthy,deaths were only observed in MaS group when concurrent with extremely higher post-transplant alanine aminotransferase(ALT,64%).However,microsteatosis(MiS)grafts didn’t affect outcomes after LT.In a cohort of Chinese patients,MaS had comprehensive effects on post-transplant outcomes with relatively lower safety threshold at 10%.Mortality gap caused by MaS grafts was observed in patients with severer ischemia reperfusion injury.Conclusions:Our study revealled the graft MaS affected the post-transplant outcomes in lower risk cutoff in Chinese patients.Further study is worthy to validate these results and investigate inner mechanism under the phenomenon.
出处 《Hepatobiliary Surgery and Nutrition》 SCIE 2020年第6期739-758,共20页 肝胆外科与营养(英文)
基金 This study is supported by Innovative Research Groups of National Natural Science Foundation of China(81721091) Major program of National Natural Science Foundation of China(91542205) National S&T Major Project(2017ZX10203205) National Natural Science Foundation of China(81902813) Zhejiang International Science and Technology Cooperation Project(2016C04003) Zhejiang Provincial Natural Science Foundation of China(LY18H030002) Zhejiang Medical Association(2019ZYC-A81) International Youth Exchange Programme by China Association for Science and Technology(2019) Tianqing Liver Diseases Research Fund(TQGB20200114) Open Fund of Key laboratory of High-Incidence-Tumor Prevention&Treatment(Guangxi Medical University),Ministry of Education.
  • 相关文献

参考文献1

二级参考文献1

共引文献10

同被引文献11

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部